Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Preliminary Results from a Phase 1/2, Open-Label, Dose-Escalation Clinical Trial of IMO-8400 in Patients with Relapsed or Refractory Waldenstrom's Macroglobulinemia Thomas, S. K., Harb, W. A., Beck, J., Nashat, G., Palomba, M., Ansell, S. M., Eradat, H., Libby, E. N., Advani, R. H., Hajdenberg, J., Heffner, L. T., Hoffman, J., Vesole, D. H., Simov, L., Wyant, N., Brevard, J., O'Leary, J., Agrawal, S. AMER SOC HEMATOLOGY. 2015
View details for Web of Science ID 000368019005018